Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 6/2021

01-06-2021 | Endocarditis | Original Article

Secular trends in the epidemiology and clinical characteristics of Enterococcus faecalis infective endocarditis at a referral center (2007–2018)

Authors: Laura Escolà-Vergé, Nuria Fernández-Hidalgo, María Nieves Larrosa, Ruben Fernandez-Galera, Benito Almirante

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 6/2021

Login to get access

Abstract

The aim of the study was to analyze the epidemiological and clinical changes in EFIE. All definite IE episodes treated at a referral center between 2007 and 2018 were registered prospectively, and a trend test was used to study etiologies over time. EFIE cases were divided into three periods, and clinical differences between them were analyzed. All episodes of E. faecalis monomicrobial bacteremia (EFMB) between 2010 and 2018 and the percentage of echocardiograms performed were retrospectively collected. Six hundred forty-eight IE episodes were studied. We detected an increase in the percentage of EFIE (15% in 2007, 25.3% in 2018, P = 0.038), which became the most prevalent causative agent of IE during the last study period. One hundred and eight EFIE episodes were analyzed (2007–2010, n = 30; 2011–2014, n = 22; 2015–2018, n = 56). The patients in the last period were older (median 70.9 vs 66.5 vs 76.3 years, P = 0.015) and more frequently had an abdominal origin of EFIE (20% vs 13.6% vs 42.9%, P = 0.014), fewer indications for surgery (63.3% vs 54.6% vs 32.1%, P = 0.014), and non-significantly lower in-hospital mortality (30% vs 18.2% vs 12.5%, P = 0.139). There was an increase in the percentage of echocardiograms performed in patients with EFMB (30% in 2010, 51.2% in 2018, P = 0.014) and EFIE diagnoses (15% in 2010, 32.6% in 2018, P = 0.004). E. faecalis is an increasing cause of IE in our center, most likely due to an increase in the percentage of echocardiograms performed. The factors involved in clinical changes in EFIE should be thoroughly studied.
Literature
1.
go back to reference Selton-Suty C, Célard M, Le Moing V et al (2012) Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey. Clin Infect Dis 54:1230–1239CrossRef Selton-Suty C, Célard M, Le Moing V et al (2012) Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey. Clin Infect Dis 54:1230–1239CrossRef
2.
go back to reference Chirouze C, Athan E, Alla F et al (2013) Enterococcal endocarditis in the beginning of the 21st century: analysis from the International Collaboration on Endocarditis-Prospective Cohort Study. Clin Microbiol Infect 19:1140–1147CrossRef Chirouze C, Athan E, Alla F et al (2013) Enterococcal endocarditis in the beginning of the 21st century: analysis from the International Collaboration on Endocarditis-Prospective Cohort Study. Clin Microbiol Infect 19:1140–1147CrossRef
3.
go back to reference Muñoz P, Kestler M, De Alarcon A et al (2015) Current epidemiology and outcome of infective endocarditis. Medicine (Baltimore) 94:e1816CrossRef Muñoz P, Kestler M, De Alarcon A et al (2015) Current epidemiology and outcome of infective endocarditis. Medicine (Baltimore) 94:e1816CrossRef
4.
go back to reference Fernández-Hidalgo N, Almirante B, Tornos P et al (2008) Contemporary epidemiology and prognosis of health care–associated infective endocarditis. Clin Infect Dis 47:1287–1297CrossRef Fernández-Hidalgo N, Almirante B, Tornos P et al (2008) Contemporary epidemiology and prognosis of health care–associated infective endocarditis. Clin Infect Dis 47:1287–1297CrossRef
5.
go back to reference Wright A, Otome O, Harvey C, Bowe S, Athan E (2018) The current epidemiology of injecting drug use-associated infective endocarditis in Victoria, Australia in the midst of increasing crystal methamphetamine use. Heart Lung Circ 27:484–488CrossRef Wright A, Otome O, Harvey C, Bowe S, Athan E (2018) The current epidemiology of injecting drug use-associated infective endocarditis in Victoria, Australia in the midst of increasing crystal methamphetamine use. Heart Lung Circ 27:484–488CrossRef
6.
go back to reference Olmos C, Vilacosta I, Fernández-Pérez C et al (2017) The evolving nature of infective endocarditis in Spain: a population-based study (2003 to 2014). J Am Coll Cardiol 70:2795–2804CrossRef Olmos C, Vilacosta I, Fernández-Pérez C et al (2017) The evolving nature of infective endocarditis in Spain: a population-based study (2003 to 2014). J Am Coll Cardiol 70:2795–2804CrossRef
7.
go back to reference Østergaard L, Bruun NE, Voldstedlund M et al (2019) Prevalence of infective endocarditis in patients with positive blood cultures: a Danish nationwide study. Eur Heart J 40:3237–3244CrossRef Østergaard L, Bruun NE, Voldstedlund M et al (2019) Prevalence of infective endocarditis in patients with positive blood cultures: a Danish nationwide study. Eur Heart J 40:3237–3244CrossRef
8.
go back to reference Dahl A, Iversen K, Tonder N et al (2019) Prevalence of infective endocarditis in Enterococcus faecalis bacteremia. J Am Coll Cardiol 74:193–201CrossRef Dahl A, Iversen K, Tonder N et al (2019) Prevalence of infective endocarditis in Enterococcus faecalis bacteremia. J Am Coll Cardiol 74:193–201CrossRef
9.
go back to reference Fernández-Hidalgo N, Escolà-Vergé L (2019) Enterococcus faecalis bacteremia: consider an echocardiography, but consult an infectious diseases specialist. J Am Coll Cardiol 74:202–204CrossRef Fernández-Hidalgo N, Escolà-Vergé L (2019) Enterococcus faecalis bacteremia: consider an echocardiography, but consult an infectious diseases specialist. J Am Coll Cardiol 74:202–204CrossRef
10.
go back to reference Habib G, Erba PA, Iung B et al (2019) Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study. Eur Heart J 40:3222–3232CrossRef Habib G, Erba PA, Iung B et al (2019) Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study. Eur Heart J 40:3222–3232CrossRef
11.
go back to reference Pizzi MN, Roque A, Fernández-Hidalgo N et al (2015) Improving the diagnosis of infective endocarditis in prosthetic valves and intracardiac devices with 18F-Fluordeoxyglucose positron emission tomography/computed tomography angiography: initial results at an infective endocarditis referral center. Circulation 132:1113–1126CrossRef Pizzi MN, Roque A, Fernández-Hidalgo N et al (2015) Improving the diagnosis of infective endocarditis in prosthetic valves and intracardiac devices with 18F-Fluordeoxyglucose positron emission tomography/computed tomography angiography: initial results at an infective endocarditis referral center. Circulation 132:1113–1126CrossRef
12.
go back to reference Escolà-Vergé L, Peghin M, Givone F et al (2020) Prevalence of colorectal disease in Enterococcus faecalis infective endocarditis: results of an observational multicenter study. Rev Esp Cardiol (Engl Ed) 73(9):711–717 Escolà-Vergé L, Peghin M, Givone F et al (2020) Prevalence of colorectal disease in Enterococcus faecalis infective endocarditis: results of an observational multicenter study. Rev Esp Cardiol (Engl Ed) 73(9):711–717
13.
go back to reference Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383CrossRef Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383CrossRef
14.
go back to reference Li JS, Sexton DJ, Mick N et al (2000) Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 30:633–638CrossRef Li JS, Sexton DJ, Mick N et al (2000) Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 30:633–638CrossRef
15.
go back to reference Habib G, Lancellotti P, Antunes MJ et al (2015) 2015 ESC guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the European Society of Cardiology (ESC) endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J 36:3075–3128CrossRef Habib G, Lancellotti P, Antunes MJ et al (2015) 2015 ESC guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the European Society of Cardiology (ESC) endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J 36:3075–3128CrossRef
16.
go back to reference Benito N, Miró JM, de Lazzari E et al (2009) Health care–associated native valve endocarditis in patients with no history of injection drug use: current importance of non-nosocomial acquisition. Ann Intern Med 150:586–594CrossRef Benito N, Miró JM, de Lazzari E et al (2009) Health care–associated native valve endocarditis in patients with no history of injection drug use: current importance of non-nosocomial acquisition. Ann Intern Med 150:586–594CrossRef
17.
go back to reference Horstkotte D (2004) Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary the task force on infective endocarditis of the European Society of Cardiology. Eur Heart J 25:267–276CrossRef Horstkotte D (2004) Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary the task force on infective endocarditis of the European Society of Cardiology. Eur Heart J 25:267–276CrossRef
18.
go back to reference Habib G, Hoen B, Tornos P et al (2009) Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the task force on the prevention, diagnosis, and treatment of infective endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and by the International Society of Chemotherapy (ISC) for infection and cancer. Eur Heart J 30:2369–2413CrossRef Habib G, Hoen B, Tornos P et al (2009) Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the task force on the prevention, diagnosis, and treatment of infective endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and by the International Society of Chemotherapy (ISC) for infection and cancer. Eur Heart J 30:2369–2413CrossRef
19.
go back to reference Levy MM, Fink MP, Marshall JC et al (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 31:1250–1256CrossRef Levy MM, Fink MP, Marshall JC et al (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 31:1250–1256CrossRef
20.
go back to reference Kellum JA, Levin N, Bouman C, Lameire N (2002) Developing a consensus classification system for acute renal failure. Curr Opin Crit Care 8:509–514CrossRef Kellum JA, Levin N, Bouman C, Lameire N (2002) Developing a consensus classification system for acute renal failure. Curr Opin Crit Care 8:509–514CrossRef
21.
go back to reference Bouza E, Kestler M, Beca T et al (2015) The NOVA score: a proposal to reduce the need for transesophageal echocardiography in patients with enterococcal bacteremia. Clin Infect Dis 60:528–535CrossRef Bouza E, Kestler M, Beca T et al (2015) The NOVA score: a proposal to reduce the need for transesophageal echocardiography in patients with enterococcal bacteremia. Clin Infect Dis 60:528–535CrossRef
22.
go back to reference Berge A, Krantz A, Östlund H, Nauclér P, Rasmussen M (2019) The DENOVA score efficiently identifies patients with monomicrobial Enterococcus faecalis bacteremia where echocardiography is not necessary. Infection 47:45–50CrossRef Berge A, Krantz A, Östlund H, Nauclér P, Rasmussen M (2019) The DENOVA score efficiently identifies patients with monomicrobial Enterococcus faecalis bacteremia where echocardiography is not necessary. Infection 47:45–50CrossRef
23.
go back to reference Forestier E, Roubaud-Baudron C, Fraisse T et al (2019) Comprehensive geriatric assessment in older patients suffering from infective endocarditis. A prospective multicentric cohort study. Clin Microbiol Infect 25:1246–1252CrossRef Forestier E, Roubaud-Baudron C, Fraisse T et al (2019) Comprehensive geriatric assessment in older patients suffering from infective endocarditis. A prospective multicentric cohort study. Clin Microbiol Infect 25:1246–1252CrossRef
24.
go back to reference Fernández-Hidalgo N, Almirante B, Gavaldà J et al (2013) Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treating Enterococcus faecalis infective endocarditis. Clin Infect Dis 56:1261–1268CrossRef Fernández-Hidalgo N, Almirante B, Gavaldà J et al (2013) Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treating Enterococcus faecalis infective endocarditis. Clin Infect Dis 56:1261–1268CrossRef
25.
go back to reference Escolà-Vergé L, Fernández-Hidalgo N, Rodríguez-Pardo D et al (2019) Teicoplanin for treating enterococcal infective endocarditis: a retrospective observational study from a referral centre in Spain. Int J Antimicrob Agents 53:165–170CrossRef Escolà-Vergé L, Fernández-Hidalgo N, Rodríguez-Pardo D et al (2019) Teicoplanin for treating enterococcal infective endocarditis: a retrospective observational study from a referral centre in Spain. Int J Antimicrob Agents 53:165–170CrossRef
26.
go back to reference Fernández-Hidalgo N, Almirante B, Tornos P et al (2011) Prognosis of left-sided infective endocarditis in patients transferred to a tertiary-care hospital--prospective analysis of referral bias and influence of inadequate antimicrobial treatment. Clin Microbiol Infect 17:769–775CrossRef Fernández-Hidalgo N, Almirante B, Tornos P et al (2011) Prognosis of left-sided infective endocarditis in patients transferred to a tertiary-care hospital--prospective analysis of referral bias and influence of inadequate antimicrobial treatment. Clin Microbiol Infect 17:769–775CrossRef
Metadata
Title
Secular trends in the epidemiology and clinical characteristics of Enterococcus faecalis infective endocarditis at a referral center (2007–2018)
Authors
Laura Escolà-Vergé
Nuria Fernández-Hidalgo
María Nieves Larrosa
Ruben Fernandez-Galera
Benito Almirante
Publication date
01-06-2021
Publisher
Springer Berlin Heidelberg
Keyword
Endocarditis
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 6/2021
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-020-04117-x

Other articles of this Issue 6/2021

European Journal of Clinical Microbiology & Infectious Diseases 6/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine